Sterrx, Llc Today Announced The Voluntary Nationwide Recall Of Approximately 240 Lots Within Their Expiry Period Due To Equipment And Process Issues That Could Lead To A Lack Of Sterility Assurance For Products Intended To Be Sterile. To Date, Sterrx, Llc Has Not Received Reports Of Any Product Complaints Or Adverse Events Associated With This Issue. Sterrx, Llc Has Initiated This Voluntary Recall To The Hospital Pharmacy Level Out Of An Abundance Of Caution.This Recall Is Being Conducted With The Knowledge Of The U.S. Food And Drug Administration.The Lot Numbers Being Recalled Were Distributed To Hospitals Nationwide From December 2020
